APA (7th ed.) Citation

Kamegai, K., Iwamoto, N., Togano, T., Maeda, K., Takamatsu, Y., Miyazato, Y., . . . Ohmagari, N. (2022). A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy. International journal of infectious diseases, 121, 85-88. https://doi.org/10.1016/j.ijid.2022.04.058

Chicago Style (17th ed.) Citation

Kamegai, Kohei, et al. "A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy." International Journal of Infectious Diseases 121 (2022): 85-88. https://doi.org/10.1016/j.ijid.2022.04.058.

MLA (9th ed.) Citation

Kamegai, Kohei, et al. "A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy." International Journal of Infectious Diseases, vol. 121, 2022, pp. 85-88, https://doi.org/10.1016/j.ijid.2022.04.058.